Biobohemia announced call for participation in the cancer vaccines upgrade initiative (Vacc 100). The upgrade comprises development of analogs of cellular cancer vaccines using antigenic essence technology. Individual scientists, groups, institutes, foundations, sponsors, advisers, legal companies, and incubators are invited. Several tens vaccines are planned to be upgraded. The scientific basis for such an upgrade is summarized in a recent publication ("
Antigenic essence: upgrade of cellular cancer vaccines", Cancers, 2021, 13, 774). The initiative aims to consolidate academic science with the financial capabilities of investors. Organizers of the initiative will provide coordination and support to participants.
In July 2021, the results of this challenge will be summarized and the initial list of participants in the initiative will be published. Information will also be provided on which organizations are developing the antigenic essence vaccines and against which cancer types, and which organizations are participating in a supportive role.
The online application form for participation in the initiative is presented below.
Also offline pdf application form is available, you can fill it out and send it to our Email: vacc100@biobohemia.com